This UCLA version I have seen mentioned before concerns me. While I hope it proves to be highly effective for the sake of cancer patients, if it is 100 times more effective than our DCVAX are we exposed to an expedited trial where UCLA sells patent to say Merck?
Market Data 
Markets 
AI
